SK285386B6 - Tricyklické delta3-piperidíny ako farmaceutiká a spôsob ich prípravy - Google Patents

Tricyklické delta3-piperidíny ako farmaceutiká a spôsob ich prípravy Download PDF

Info

Publication number
SK285386B6
SK285386B6 SK433-2001A SK4332001A SK285386B6 SK 285386 B6 SK285386 B6 SK 285386B6 SK 4332001 A SK4332001 A SK 4332001A SK 285386 B6 SK285386 B6 SK 285386B6
Authority
SK
Slovakia
Prior art keywords
formula
group
compound
alk
compounds
Prior art date
Application number
SK433-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK4332001A3 (en
Inventor
Ludo Edmond Josephine Kennis
Josephus Carolus Mertens
Mirielle Braeken
Original Assignee
Janssen Pharmaceutica N. V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N. V. filed Critical Janssen Pharmaceutica N. V.
Publication of SK4332001A3 publication Critical patent/SK4332001A3/sk
Publication of SK285386B6 publication Critical patent/SK285386B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SK433-2001A 1998-10-06 1999-10-01 Tricyklické delta3-piperidíny ako farmaceutiká a spôsob ich prípravy SK285386B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203371 1998-10-06
PCT/EP1999/007420 WO2000020423A1 (en) 1998-10-06 1999-10-01 Tricyclic δ3-piperidines as pharmaceuticals

Publications (2)

Publication Number Publication Date
SK4332001A3 SK4332001A3 (en) 2001-12-03
SK285386B6 true SK285386B6 (sk) 2006-12-07

Family

ID=8234192

Family Applications (1)

Application Number Title Priority Date Filing Date
SK433-2001A SK285386B6 (sk) 1998-10-06 1999-10-01 Tricyklické delta3-piperidíny ako farmaceutiká a spôsob ich prípravy

Country Status (28)

Country Link
US (1) US6352999B1 (xx)
EP (1) EP1119570B1 (xx)
JP (1) JP4590102B2 (xx)
KR (1) KR20010071844A (xx)
CN (1) CN1131868C (xx)
AR (1) AR023679A1 (xx)
AT (1) ATE269337T1 (xx)
AU (1) AU759199B2 (xx)
BG (1) BG64871B1 (xx)
BR (1) BR9913108A (xx)
CA (1) CA2346082C (xx)
CZ (1) CZ20011105A3 (xx)
DE (1) DE69918148T2 (xx)
EE (1) EE04680B1 (xx)
ES (1) ES2222735T3 (xx)
HK (1) HK1038009A1 (xx)
HU (1) HUP0103749A3 (xx)
ID (1) ID28451A (xx)
IL (2) IL142444A0 (xx)
NO (1) NO20011402L (xx)
NZ (1) NZ510116A (xx)
PL (1) PL347179A1 (xx)
RU (1) RU2226194C2 (xx)
SK (1) SK285386B6 (xx)
TR (1) TR200100953T2 (xx)
TW (1) TWI244485B (xx)
UA (1) UA70961C2 (xx)
WO (1) WO2000020423A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ
WO2003004501A2 (en) * 2001-07-05 2003-01-16 Pharmacia & Upjohn Company (hetero) aryl substituted benzofurans as 5-ht ligands
EP1490338B1 (en) * 2002-04-03 2011-08-24 Orion Corporation Use of an alfa2-adrenoreceptor antagonist for cns-related diseases
BRPI0509893A (pt) 2004-04-12 2007-10-30 Taisho Pharmaceutical Co Ltd composto de amina cìclica
BRPI0608353A2 (pt) 2005-02-17 2009-12-01 Wyeth Corp derivados de indol, benzotiofeno, benzofurano e indeno cicloalquilfundidos
DE102005038947A1 (de) * 2005-05-18 2006-11-30 Grünenthal GmbH Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
CN105636946B (zh) * 2013-07-25 2017-12-19 东亚St 株式会社 制备苯甲酰胺衍生物的方法、用于制备苯甲酰胺的新型中间体以及制备新型中间体的方法
CN103755715B (zh) * 2013-12-26 2015-12-09 武汉理工大学 苯并呋喃并[2,3-c]吡啶化合物及其合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3522959A1 (de) 1985-06-27 1987-01-08 Merck Patent Gmbh Indolderivate
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
US4985422A (en) * 1988-04-27 1991-01-15 Glaxo Group Limited Lactam derivatives
US5100891A (en) * 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
PT942911E (pt) * 1996-12-06 2002-04-29 Abbott Lab Compostos alfa 1 adrenergicos de benzopiranopirrolo e benzopiranopiridina
UA52681C2 (uk) * 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ

Also Published As

Publication number Publication date
HUP0103749A3 (en) 2003-03-28
DE69918148T2 (de) 2005-07-28
EP1119570B1 (en) 2004-06-16
TWI244485B (en) 2005-12-01
BG64871B1 (bg) 2006-07-31
AU759199B2 (en) 2003-04-10
AU6334299A (en) 2000-04-26
BG105334A (en) 2001-11-30
UA70961C2 (uk) 2004-11-15
US6352999B1 (en) 2002-03-05
EE04680B1 (et) 2006-08-15
DE69918148D1 (de) 2004-07-22
JP4590102B2 (ja) 2010-12-01
HK1038009A1 (en) 2002-03-01
ATE269337T1 (de) 2004-07-15
BR9913108A (pt) 2001-05-08
ES2222735T3 (es) 2005-02-01
SK4332001A3 (en) 2001-12-03
NO20011402D0 (no) 2001-03-20
NO20011402L (no) 2001-03-20
KR20010071844A (ko) 2001-07-31
WO2000020423A1 (en) 2000-04-13
EP1119570A1 (en) 2001-08-01
JP2002526547A (ja) 2002-08-20
ID28451A (id) 2001-05-24
HUP0103749A2 (hu) 2002-02-28
IL142444A (en) 2008-03-20
CN1131868C (zh) 2003-12-24
IL142444A0 (en) 2002-03-10
CA2346082A1 (en) 2000-04-13
RU2226194C2 (ru) 2004-03-27
CA2346082C (en) 2010-02-16
CN1321158A (zh) 2001-11-07
NZ510116A (en) 2002-10-25
PL347179A1 (en) 2002-03-25
TR200100953T2 (tr) 2001-09-21
CZ20011105A3 (cs) 2001-12-12
AR023679A1 (es) 2002-09-04
EE200100210A (et) 2002-06-17

Similar Documents

Publication Publication Date Title
EP1019408B1 (en) 1,2,3,4-TETRAHYDRO-BENZOFURO[3,2-c]PYRIDINE DERIVATIVES
JP4590101B2 (ja) α2−アンタゴニストとしての三環性Δ3−ピペリジン類
SK285386B6 (sk) Tricyklické delta3-piperidíny ako farmaceutiká a spôsob ich prípravy
US6576640B1 (en) Benzisoxazoles and phenones as α2-antagonists
JP4580555B2 (ja) α2アンタゴニストとしてのベンゾチエノ[3,2−c]ピリジン類
MXPA01003512A (en) TRICYCLIC&amp;Dgr;3-PIPERIDINES AS PHARMACEUTICALS
MXPA01003514A (en) BENZOTHIENO[3,2-c]PYRIDINES AS&amp;agr;2
MXPA01006353A (en) Benzisoxazoles and phenones as alpha 2-antagonists
MXPA01003517A (en) TRICYCLIC&amp;Dgr;3-PIPERIDINES AS&amp;agr;2